BiotechTube
Home/Endece/James Yarger, Ph.D.
JY

James Yarger, Ph.D.

Board Member, President, Chief Executive Officer, Chief Scientific Officer

Endece

Therapeutic Areas

Neurodegenerative DiseasesMultiple Sclerosis

Endece Pipeline

DrugIndicationPhase
NDC-1308Multiple Sclerosis / Neurodegenerative DiseasePreclinical